SFX by Ex Libris Inc.

Title:	The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share
Source:	Human Molecular Genetics [0964-6906] Kottyan, L C yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Dattwyler, Raymond J J. "A comparison of two treatment regimens of ceftriaxone in late Lyme disease." Wiener klinische Wochenschrift 117.11-12 (2005): 393-7.
description	2.	Terrie, Yvette C. "Living with lupus: genetics, the environment, and hormones may play a role in the development of lupus." Pharmacy times 80.3 (2014): 86-.
description	3.	Cimperman, R. "Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis." Scandinavian journal of infectious diseases 37.6-7 (2005): 449-54.
description	4.	Viljanen, M. "Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study." European journal of clinical microbiology & infectious diseases 26.8 (2007): 571-81.
description	5.	Kosinski, L. "Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease." New England Journal of Medicine, The 345.2 (2001): 85-92.
description	6.	Sackeim, H A A. "A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy." Neurology 70.13 (2008): 992-1003.
description	7.	Ghazeeri, G. "Immunological differences in women compared with men: overview and contributing factors." American journal of reproductive immunology (1989) 66.3 (2011): 163-169.
description	8.	Mason, Mary-Claire C. "Living life with lupus." Nursing standard 24.45 (2010): 25-25.
description	9.	V Goëb, F Dubreuil P Cabre D. "Letter to the Editor." Lupus 13.1 (2004): 215-65.
description	10.	Zhang, X. "Economic impact of Lyme disease." Emerging infectious diseases 12.4 (2006): 653-60.
description	11.	Krupp, L B B. "Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial." Neurology 60.12 (2003): 1923-30.
description	12.	Dattwyler, R J J. "Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease." New England Journal of Medicine, The 337.5 (1997): 289-94.
description	13.	Ramanathan, Rhea P. "Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial." Annals of internal medicine 138.9 (2003): 697-704.
description	14.	Karkkonen, K. "Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis." Scandinavian journal of infectious diseases 33.4 (2001): 259-262.
description	15.	Kaplan, R F F. "Cognitive function in post-treatment Lyme disease: do additional antibiotics help?" Neurology 60.12: 1916-1922.
description	16.	Bever, C T T. "Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology." Neurology Publish Ahead of Print.7 (2007): 91-102.
description	17.	Donta, V T. "Treatment of patients with persistent symptoms and a history of Lyme disease." The New England journal of medicine 345.19 (2001): 1424-1424.
description	18.	Donta, S T T. "Tetracycline therapy for chronic Lyme disease." Clinical infectious diseases 25.S1 (1997): -6.
description	19.	Dattwyler, R J J. "Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin." Lancet, The 1.8596 (1988): 1191-4.
description	20.	Steere, A C C. "Successful treatment of Lyme encephalopathy with intravenous ceftriaxone." The journal of infectious diseases 180.2 (1999): 377-83.